Hired someone new and exciting? Promoting a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.
And here is our regular feature in which we highlight a different person each week. This time around, we note that Intellia Therapeutics (NTLA) hired Laura Sepp-Lorenzino as executive vice president and chief scientific officer. Previously, she worked at Vertex Pharmaceuticals (VRTX), where she was vice president, head of nucleic acid therapies, research leadership.
About the Author Reprints
